ArticleThe Journal of experimental medicine2013

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.

Andrew T McGuire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.